The Physiological concept:
The physiological approach utilized to formulate VITALIFE is of paramount importance. Rather than emulate the desired end product with a synthetic substance, the goal was to identify the messenger that would allow the body to increase the desired end product by increasing the body's own production. Once identified, the messenger was mimicked and utilized to increase the desired end product endogenously.
In the case of VITALIFE, this approach allowed for the identification of the various hypothalamic specific poly-peptides (collectively referred to as hypothalamic poly-peptide combinants) which form GHRH. GHRH is responsible for the release of growth hormone from the pituitary. Thus, VITALIFE (various hypothalamic specific poly-peptide combinants) is a GHRH analog or mimicker, emulating the function of GHRH and resulting in an increase in the natural pulsatile release of endogenous GH.
The Poly-peptide sequencing technology:
The sequencing technology utilized to manufacture VITALIFE is far more advanced than any currently available and estimated by some scientists to be 15 to 20 years ahead of its time. Very simply this technology allows for the creation of any poly-peptide sequence. In this specific case, it allows for the creation of hormonal messenger analogs, mimicking the action of the body's own endogenous hormonal messengers. It is important to realize that by simply blending amino acids or combining amino acid stacks will not accomplish the task achieved by VITALIFE.
To best understand this concept, think of your body's own composition. If you take the exact chemical constituents that make up your own body down to every single component, add the necessary amount of water and bring the resulting concoction up to 98.7 Fahrenheit, would you have a clone of yourself? How about another human being? How about anything that even resembles life? The answer is, obviously not. However the real question that must be asked is, what makes you physically different from the concoction you just created? The answer: It's "HOW" you were put together that makes you different from the concoction that you attempted to put together and NOT the ingredients. This is the reason why VITALIFE is so efficacious. The uniqueness of "How" the ingredients are put together provides the beneficial properties of VITALIFE.
The Trans-dermal delivery method:
A relatively uncharted area of science incorporates the utilization of EFAs (essential fatty acids) as a mechanical means of therapy, such as employment in a drug delivery system.
Already, the delivery method for a number of unique experimental treatment modalities such as B lymphocyte stimulators as well as established treatment modalities such as growth hormone releasing hormone analogs utilizing poly-peptide synthesis technologies (VITALIFE) have been achieved utilizing EFAs as the mode of transport. The delicate nature of these poly-peptide sequences renders them susceptible to denaturing by gastrointestinal acids and digestive enzymes as well as the fact that our modern day society has created a tremendous vacillation in gut function and poor gut absorption.
This results in preventing oral delivery mechanism from being a viable option. Conventional paraenteral routes (IV, IM, or SQ injections) raise the issue of compliance due to the necessity for daily injections as well the concern for convenience. The very sensitive nature of these poly-peptide structures, which result in actions analogous to hormones, prevents traditional drug delivery mechanisms from being utilized.
Utilizing specific combinations of EFAs with other carrier substances, these new poly-peptide treatment modalities now have a way of being delivered into the system in a trans-dermal manner without the concerns of denaturing or issues regarding compliance. Evito is one such trans-dermal delivery modality used to deliver the active constituents of VITALIFE. Furthermore, not only do these EFA trans-dermal transport delivery mechanisms allow for convenient dosing, but they have also been actually found to contribute to stabilizing the poly-peptide structures. Not surprisingly, assimilation into the system is also achieved beyond that of other delivery mechanisms including other non-EFA trans-dermal delivery mechanisms.
Summary
As the body ages, though still pulsatile in nature, the surges of hGH decline. These declining levels occur very early in life, after complete height is reached or shortly thereafter. The secretion levels diminish further with aging. Other contributing factors include general physical condition, activity level and diet. VITALIFE is an analog of Growth Hormone Releasing Hormone (GHRH) that stimulates the pituitary to produce and release more of the body's own hGH. In other words, it stimulates the body's production of human growth hormone in a pulsatile manner at every application time during the day. This increase in endogenous hGH during the normal 24-hour cycle offers many benefits over conventional introduction of injected hGH, such as:
- Stimulation of the body's own pituitary gland, rather than its suppression, should in time increase its vigor. (preliminary blood work has supported this hypothesis). This should mean continuing increases in the overall general health of the endocrine system. (Injected hGH has exactly the opposite effect. By supplying synthetic hGH, the hypothalamus-pituitary-adrenal axis is effectively inhibited, and no studies on adults have been conducted to discover its long-term effects).
- Much less costly, trans-dermal delivered GHRH retails at $195 retail per month vs. $1500 -$2200 per month via other delivery systems. This price puts VITALIFE within the purchasing power of the general public.
- More normal hGH release in a pulsatile manner decreases somatostatin response, therefore allowing hGH serum levels to remain elevated for two hours or more per application.
- Tests have shown consistent decreases in IGF-1 levels using VITALIFE, rather than increases as seen with hGH injections. This may decrease the likelihood of increasing cancer growth in some types of cancer.
- Ease of application is greater with topical lotion vs. injection, meaning the applications may be done at home or on the road at any time.
- Unlike injected hGH, there are no allergic reactions to one's own hGH secreted from one's own pituitary, making this product virtually free from side effects.
